<br />
FEATURED REPORT<br />
Vaccines<br />
New Pathways to<br />
Engaging the<br />
Immune System<br />
MARCH 2025<br />
01 Opportunities and Obstacles for Personalized<br />
Cancer Vaccines<br />
Ilona Baraniak-Lang and Anna-Lena Amend<br />
06 Translating Transfusion-Medicine Technology<br />
to Cancer-Vaccine Manufacturing: A Novel<br />
Immunization Approach Based on Inactivated<br />
Autologous Tumor Cells<br />
Brian Gazaille with Raymond P. Goodrich<br />
12 $GYDQFLQJ*HQH0RGLȴHGΖQDFWLYDWHG<br />
HIV-1 Vaccines Through Clinical Studies:<br />
Novel Approaches Merit Specialized<br />
Manufacturing Capabilities<br />
Brian Gazaille with Eunsil Choi and<br />
Eric Le Forestier<br />
18 Bottlenecks in RNA Delivery:<br />
Optimization of LNP<br />
Delivery Systems<br />
Dan Peer<br />
Cell Culture<br />
Increased consistency.<a title="March 2025 - Featured Report page 1" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=1"> FEATURED REPORT Vaccines New Pathways to En</a>
<a title="March 2025 - Featured Report page 2" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=2"> Cell Culture Increased consistency. Accelerat</a>
<a title="March 2025 - Featured Report page 3" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=3"> Opportunities and Obstacles for Personalized Canc</a>
<a title="March 2025 - Featured Report page 4" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=4"> Lipid nanoparticle cancer vaccine delivery system</a>
<a title="March 2025 - Featured Report page 5" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=5"> models exist to investigate bioactivity of person</a>
<a title="March 2025 - Featured Report page 6" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=6"> disease and its associated side effects. Such spe</a>
<a title="March 2025 - Featured Report page 7" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=7"> 14 Oladejo M, Paulishak W, Wood L. Synergis</a>
<a title="March 2025 - Featured Report page 8" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=8"> Translating Transfusion-Medicine Technology to Ca</a>
<a title="March 2025 - Featured Report page 9" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=9"> Neoantigen Cancer Vaccines: Balancing Efficacy an</a>
<a title="March 2025 - Featured Report page 10" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=10"> Whereas conventional manufacturing processes do a</a>
<a title="March 2025 - Featured Report page 11" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=11"> (with exposure to antigens or addition of antigen</a>
<a title="March 2025 - Featured Report page 12" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=12"> Creating new disposables and integrated pieces of</a>
<a title="March 2025 - Featured Report page 13" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=13"> this first clinical study, we want to confirm tha</a>
<a title="March 2025 - Featured Report page 14" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=14"> Advancing Gene-Modified, Inactivated HIV-1 Vaccin</a>
<a title="March 2025 - Featured Report page 15" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=15"> manager of Naobios) told me at the end of 2024, “</a>
<a title="March 2025 - Featured Report page 16" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=16"> With current technologies, today's drug developer</a>
<a title="March 2025 - Featured Report page 17" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=17"> LEVERAGING SPECIALIZED CAPABILITIES With clinical</a>
<a title="March 2025 - Featured Report page 18" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=18"> Geopolitical and socioeconomic factors are likely</a>
<a title="March 2025 - Featured Report page 19" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=19"> CDMOs specializing in AAVs and LVs for gene-thera</a>
<a title="March 2025 - Featured Report page 20" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=20"> Bottlenecks in RNA Delivery Optimization of Lipid</a>
<a title="March 2025 - Featured Report page 21" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=21"> )LJXUH ɄElements of ionizable lipids (LEFT) and c</a>
<a title="March 2025 - Featured Report page 22" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=22"> )LJXUH ɄOverview of adverse events following mRNA</a>
<a title="March 2025 - Featured Report page 23" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=23"> The BENEFITS of mRNA vaccines outweigh the RISKS </a>
<a title="March 2025 - Featured Report page 24" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=24"> Industry Resources HCP Coverage Analysis </a>
<a title="March 2025 - Featured Report page 25" href="https://secure.viewer.zmags.com/publication/6b01f3ec?page=25"> Host Cell Protein analysis has never been </a>